ArticleClinical & developmental immunology2012
Combination immunotherapy with 4-1BBL and CTLA-4 blockade for the treatment of prostate cancer.
Kuang Youlin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this papercites it